Abstract
Background
The role of non-steroidal anti-inflammatory drugs (NSAIDs) and acetylsalicylic acid in the occurrence of diverticular bleeding (DB), complicated diverticulitis (CD), and acute diverticulitis (AD) is not yet defined.
Aim
Update a systematic review and meta-analyses of case–control and cohort studies to evaluate the association between NSAIDs or acetylsalicylic acid with DB, CD, or AD.
Methods
The study included were identified through MEDLINE, Scopus, Web of Science, and Cochrane Library databases. Sizes were pooled across studies to obtain the overall effect size. A random-effects model was used to account for different sources of variation among studies. Odds ratio (OR) with 95% confidence interval (CI) was used as a measure of effect size.
Results
Thirteen studies were included in the systematic review and meta-analysis. NSAIDs and acetylsalicylic acid use were associated with an increased risk of DB (OR: 6.90, 95% CI 3.86 to 12.35, P ˂ 0.00001, and OR 2.84, 95% CI 2.19 to 3.67, P < 0.00001, respectively). NSAIDs and acetylsalicylic acid use were also associated with increased risk of CD occurrence (OR 3.13, 95% CI 1.73 to 5.68, P = 0.0002, and OR 1.49, 95% CI 1.02 to 2.17, P = 0.04, respectively). The only study found about AD occurrence showed that NSAIDs use was not associated with AD and acetylsalicylic acid use had a low risk of AD.
Conclusion
NSAIDs and acetylsalicylic acid significantly increase the risk of DB and CD. Further studies are needed to clarify the role of NSAIDs and acetylsalicylic acid in AD. However, increasing evidence suggests caution in the use of such medications in patients with colonic diverticula.
Similar content being viewed by others
References
Strate LL, Modi R, Cohen E, Spiegel BMR (2012) Diverticular disease as a chronic illness: evolving epidemiologic and clinical insights. Am J Gastroenterol 107:1486–1493. https://doi.org/10.1038/ajg.2012.194
Tursi A, Scarpignato C, Strate LL et al (2020) Colonic diverticular disease. Nat Rev Dis Primers 6:20. https://doi.org/10.1038/s41572-020-0153-5
Swanson SM, Strate LL (2018) Acute colonic diverticulitis. Ann Intern Med 168:ITC65–ITC80. https://doi.org/10.7326/AITC201805010
Strate LL, Morris AM (2019) Epidemiology, pathophysiology, and treatment of diverticulitis. Gastroenterology 156:1282–1298.e1. https://doi.org/10.1053/j.gastro.2018.12.033
Rezapour M, Ali S, Stollman N (2018) Diverticular disease: an update on pathogenesis and management. Gut Liver 12:125–132. https://doi.org/10.5009/gnl16552
Peery AF, Crockett SD, Barritt AS et al (2015) Burden of gastrointestinal, liver, and pancreatic diseases in the United States. Gastroenterology 149:1731–1741.e3. https://doi.org/10.1053/j.gastro.2015.08.045
Bharucha AE, Parthasarathy G, Ditah I et al (2015) Temporal trends in the incidence and natural history of diverticulitis: a population-based study. Am J Gastroenterol 110:1589–1596. https://doi.org/10.1038/ajg.2015.302
Amato A, Mataloni F, Bruzzone M et al (2020) Hospital admission for complicated diverticulitis is increasing in Italy, especially in younger patients: a national database study. Tech Coloproctol 24:237–245. https://doi.org/10.1007/s10151-020-02150-8
Morris CR, Harvey IM, Stebbings WSL et al (2002) Epidemiology of perforated colonic diverticular disease. Postgrad Med J 78:654–658. https://doi.org/10.1136/pmj.78.925.654
Davies NM (1995) Toxicity of nonsteroidal anti-inflammatory drugs in the large intestine. Dis Colon Rectum 38:1311–1321. https://doi.org/10.1007/BF02049158
Davies NM (1998) Review article: non-steroidal anti-inflammatory drug-induced gastrointestinal permeability: Review: nsaid-induced gi permeability. Aliment Pharmacol Ther 12:303–320. https://doi.org/10.1046/j.1365-2036.1998.00300.x
Yuhara H, Corley DA, Nakahara F et al (2014) Aspirin and non-aspirin NSAIDs increase risk of colonic diverticular bleeding: a systematic review and meta-analysis. J Gastroenterol 49:992–1000. https://doi.org/10.1007/s00535-013-0905-z
Tan JPL, Barazanchi AWH, Singh PP et al (2016) Predictors of acute diverticulitis severity: A systematic review. Int J Surg 26:43–52. https://doi.org/10.1016/j.ijsu.2016.01.005
Kvasnovsky CL, Papagrigoriadis S, Bjarnason I (2014) Increased diverticular complications with nonsteriodal anti-inflammatory drugs and other medications: a systematic review and meta-analysis. Colorectal Dis 16:O189–O196. https://doi.org/10.1111/codi.12516
Moher D, Liberati A, Tetzlaff J et al (2009) Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement. PLoS Med 6:e1000097. https://doi.org/10.1371/journal.pmed.1000097
Longo S, Mancusi A, Stefanelli G et al (2020) Non-steroidal anti-inflammatory agents and risk of complicated diverticular disease: a systematic review and meta-analysis
Wells G, Shea B, O’Connell D et al (2014) The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses
Davey J, Turner RM, Clarke MJ, Higgins JP (2011) Characteristics of meta-analyses and their component studies in the Cochrane Database of Systematic Reviews: a cross-sectional, descriptive analysis. BMC Med Res Methodol 11:160. https://doi.org/10.1186/1471-2288-11-160
Higgins JPT (2003) Measuring inconsistency in meta-analyses. BMJ 327:557–560. https://doi.org/10.1136/bmj.327.7414.557
Sterne JA, Egger M, Moher D, Boutron I (2017) Chapter 10: Addressing reporting biases. In: Higgins JPT, Churchill R, Chandler J, Cumpston MS (editors). In: Cochrane Handbook for Systematic Reviews of Interventions version 5.2.0 (updated June 2017)
Yamada A, Sugimoto T, Kondo S et al (2008) Assessment of the risk factors for colonic diverticular hemorrhage. Dis Colon Rectum 51:116–120. https://doi.org/10.1007/s10350-007-9137-8
Humes DJ, Fleming KM, Spiller RC, West J (2011) Concurrent drug use and the risk of perforated colonic diverticular disease: a population-based case-control study. Gut 60:219–224. https://doi.org/10.1136/gut.2010.217281
Tsuruoka N, Iwakiri R, Hara M et al (2011) NSAIDs are a significant risk factor for colonic diverticular hemorrhage in elder patients: Evaluation by a case-control study: NSAID and colonic diverticular hemorrhage. J Gastroenterol Hepatol 26:1047–1052. https://doi.org/10.1111/j.1440-1746.2010.06610.x
Suzuki K, Uchiyama S, Imajyo K et al (2012) Risk factors for colonic diverticular hemorrhage: Japanese multicenter study. Digestion 85:261–265. https://doi.org/10.1159/000336351
Nagata N, Sakamoto K, Arai T et al (2015) Visceral fat accumulation affects risk of colonic diverticular hemorrhage. Int J Colorectal Dis 30:1399–1406. https://doi.org/10.1007/s00384-015-2295-6
Hreinsson JP, Palsdóttir S, Bjornsson ES (2015) The association of drugs with severity and specific causes of acute lower gastrointestinal bleeding: a prospective study. J Clin Gastroenterol. https://doi.org/10.1097/MCG.0000000000000393
Sugihara Y, Kudo S, Miyachi H et al (2016) Analysis of risk factors for colonic diverticular bleeding: a matched case-control study. Gut Liver 10:244. https://doi.org/10.5009/gnl14407
Sköldberg F, Svensson T, Olén O et al (2016) A population-based case–control study on statin exposure and risk of acute diverticular disease. Scand J Gastroenterol 51:203–210. https://doi.org/10.3109/00365521.2015.1081274
Taki M, Oshima T, Tozawa K et al (2017) Analysis of risk factors for colonic diverticular bleeding and recurrence. Medicine 96:e8090. https://doi.org/10.1097/MD.0000000000008090
Sbeit W, Khoury T, Kadah A et al (2020) Proton pump inhibitor use may increase the risk of diverticulitis but not it’s severity among patients with colonic diverticulosis: a multicenter study. JCM 9:2966. https://doi.org/10.3390/jcm9092966
Wilson RG, Smith AN, Macintyre IMC (1990) Complications of diverticular disease and non-steroidal anti-inflammatory drugs: A prospective study. Br J Surg 77:1103–1104. https://doi.org/10.1002/bjs.1800771008
Morris CR, Harvey IM, Stebbings WSL et al (2003) Anti-inflammatory drugs, analgesics and the risk of perforated colonic diverticular disease. Br J Surg 90:1267–1272. https://doi.org/10.1002/bjs.4221
Strate LL, Liu YL, Huang ES et al (2011) Use of aspirin or nonsteroidal anti-inflammatory drugs increases risk for diverticulitis and diverticular bleeding. Gastroenterology 140:1427–1433. https://doi.org/10.1053/j.gastro.2011.02.004
Author information
Authors and Affiliations
Contributions
Study concept and design: SL, EA, GL; acquisition of data: SL, FV, MV, MM, AM; analysis and interpretation of data: SL, EA, CC; drafting of the manuscript: SL, EA, GL; critical revision of the manuscript for important intellectual content: EA, CC, AV, HA, GL; study supervision: GL. All authors have approved the final draft of the manuscript.
Corresponding author
Ethics declarations
Ethics approval
No ethical approval will be needed because data were acquired from previously published studies.
Patient consent for publication
Not required.
Patient and public involvement
Patients and/or the public were not involved in the design, or conduct, or reporting or dissemination plans of this research.
Provenance and peer review
Not commissioned, internally peer-reviewed.
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Longo, S., Altobelli, E., Castellini, C. et al. Non-steroidal anti-inflammatory drugs and acetylsalicylic acid increase the risk of complications of diverticular disease: a meta-analysis of case–control and cohort studies. Int J Colorectal Dis 37, 521–529 (2022). https://doi.org/10.1007/s00384-021-04088-1
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00384-021-04088-1